VF
KURA icon

Virtu Financial’s Kura Oncology KURA Stock Holding History

Virtu Financial’s Portfolio KURA Stock Details KURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-30,615
Closed -$249K – 1941
2026
Q1 		$249K Sell
30,615
-2,976
-9% -$25.6K 0.01% 910
2025
Q4 		$349K Buy
+33,591
New +$352K 0.01% 776
2025
Q3 		– Sell
-11,283
Closed -$65K – 1800
2025
Q2 		$65K Buy
+11,283
New +$69.1K ﹤0.01% 1105
2025
Q1 		– Sell
-15,912
Closed -$139K – 1711
2024
Q4 		$139K Buy
+15,912
New +$229K 0.01% 964
2023
Q3 		– Sell
-12,233
Closed -$129K – 1608
2023
Q2 		$129K Buy
+12,233
New +$145K 0.01% 953
2021
Q1 		– Sell
-9,753
Closed -$319K – 1825
2020
Q4 		$319K Buy
+9,753
New +$343K 0.03% 615
2017
Q4 		– Sell
-68,658
Closed -$1.03M – 2702
2017
Q3 		$1.03M Buy
+68,658
New +$644K 0.05% 437

Other funds holding KURA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
ACM
Alethea Capital Management Mercer Island, Washington $241M AUM 112.74% 1-Year Est. Return

Virtu Financial's KURA Position: Q2 2026 in Review

Virtu Financial sold out of Kura Oncology (KURA) in Q2 2026, closing a stake of 30,615 shares — an estimated $249K sold.

Virtu Financial first reported a position in KURA in Q3 2017 and held it in 7 quarters. The position peaked at $1.03M in Q3 2017. 221 funds tracked by Wall St. Rank hold KURA as of Q2 2026.

  • Virtu Financial reported no remaining Kura Oncology position as of Q2 2026 after selling out during the quarter.
  • Virtu Financial sold 30,615 Kura Oncology shares in Q2 2026, an estimated $249K.
  • Virtu Financial first reported a position in Kura Oncology in Q3 2017 and held it in 7 quarters.
  • Virtu Financial's Kura Oncology position peaked at $1.03M in Q3 2017.
  • 221 funds tracked by Wall St. Rank held Kura Oncology as of Q2 2026.

Based on Virtu Financial's 13F filing for Q2 2026, filed 13 Aug 2026.